On Monday, people in the United States started receiving the Pfizer-BioNTech COVID-19 vaccine, developed in cooperation between the US-based Pfizer and the German-based BioNTech SE companies. The vaccine was authorized by the US Food and Drug Administration (FDA) on Friday.